Global Investigations Review - The law and practice of international investigations

image

Novartis execs on compliance: “Why be afraid of the truth?”

By Adam Dobrik

05 October 2020

Novartis execs on compliance: “Why be afraid of the truth?” Novartis’s Shannon Thyme Klinger and Klaus Moosmayer

Novartis’s Shannon Thyme Klinger and Klaus Moosmayer talk to GIR about how the pharmaceutical company changed its approach to compliance in the midst of a series of government investigations.